3-(4-Carboxyphenyl)-5-Methoxybenzoic acid
- $325 - $1171
- Product name: 3-(4-Carboxyphenyl)-5-Methoxybenzoic acid
- CAS: 1261931-39-8
- MF: C15H12O5
- MW: 272.25
- EINECS:
- MDL Number:MFCD18320284
- Synonyms:3-(4-Carboxyphenyl)-5-Methoxybenzoic acid;1,1'-Biphenyl]-3,4'-dicarboxylic acid, 5-methoxy-
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- TRC
Package
- 5MG
- 500mg
- 5g
- ManufacturerAK Scientific
- Product number5109AA
- Product description5-Methoxy-[1,1'-biphenyl]-3,4'-dicarboxylicacid
- Packaging5g
- Price$1171
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0390810
- Product description5-METHOXY-[1,1'-BIPHENYL]-3,4'-DICARBOXYLIC ACID 95.00%
- Packaging5MG
- Price$500.08
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12160852
- Product description5-Methoxy-[1,1'-biphenyl]-3,4'-dicarboxylicacid 95+%
- Packaging5g
- Price$790
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC181443
- Product description3-(4-Carboxyphenyl)-5-methoxybenzoicacid
- Packaging500mg
- Price$325
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 5109AA | 5-Methoxy-[1,1'-biphenyl]-3,4'-dicarboxylicacid | 5g | $1171 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0390810 | 5-METHOXY-[1,1'-BIPHENYL]-3,4'-DICARBOXYLIC ACID 95.00% | 5MG | $500.08 | 2021-12-16 | Buy |
Crysdot | CD12160852 | 5-Methoxy-[1,1'-biphenyl]-3,4'-dicarboxylicacid 95+% | 5g | $790 | 2021-12-16 | Buy |
TRC | C181443 | 3-(4-Carboxyphenyl)-5-methoxybenzoicacid | 500mg | $325 | 2021-12-16 | Buy |
Properties
storage temp. :2-8°C
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|